New to The Street Extends Partnership with Acurx Pharmaceuticals

New to The Street, a business television and media platform, has renewed its partnership with Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) for another 6-month media campaign. The initiative will feature long-form interviews on Fox Business and Bloomberg Television, over 50 commercials monthly, and broadened exposure via New to The Street's YouTube channel and digital networks.

Acurx Pharmaceuticals, known for developing novel antibiotics for drug-resistant infections, aims to increase its visibility among key stakeholders. CEO David P. Luci expressed enthusiasm for leveraging New to The Street's media reach to promote their mission of introducing life-saving antibiotics.

The campaign will include monthly interviews with Jane King, broadcasts on national TV, and prominent billboard placements in key locations alongside a comprehensive digital presence.